LYNDSE ASHLEY: Open Payments
NPI 1861736738 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 120 payments from 17 companies in 2025. Trend: 2023 $1,166 · 2024 $1,190 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $342 |
| ABBVIE INC. | 30 | $265 |
| Otsuka America Pharmaceutical, Inc. | 18 | $235 |
| Supernus Pharmaceuticals, Inc. | 6 | $115 |
| Janssen Pharmaceuticals, Inc | 6 | $106 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Alkermes, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Corium, LLC | 1 | $35 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Qelbree, SPRAVATO, Jornay PM, ABILIFY MAINTENA, FANAPT.
Industry payments across OK — which companies pay providers there.
